Skip to main content
HR 5279 116th Congress House Health Animal protection and human-animal relationships Business records Congressional oversight Consumer affairs Cosmetics and personal care Drug safety, medical device, and laboratory regulation Government information and archives Inflation and prices Internet and video services Internet, web applications, social media Licensing and registrations Manufacturing Performance measurement Product safety and quality User charges and fees

Cosmetic Safety Enhancement Act of 2019

Introduced: December 3, 2019 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 11, 2020
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Mar 11, 2020
Subcommittee Consideration and Mark-up Session Held.
Dec 4, 2019
Referred to the Subcommittee on Health.
Dec 3, 2019
Introduced in House
Dec 3, 2019
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cosmetic Safety Enhancement Act of 2019

This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.

What's happening now March 11, 2020

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

 Related & companion bills 1
  • S 726 Related bill Personal Care Products Safety Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5279: Cosmetic Safety Enhancement Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5279/
MLA
"H.R. 5279: Cosmetic Safety Enhancement Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5279/.
Bluebook (legal)
H.R. 5279, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5279/.
Markdown link
[H.R. 5279: Cosmetic Safety Enhancement Act of 2019](https://openamerica.io/bill/116-HR-5279/)
Report a problem